Common use of NOTIFICATIONS AND SUBMISSION OF REPORTS Clause in Contracts

NOTIFICATIONS AND SUBMISSION OF REPORTS. Unless otherwise stated in writing after the Effective Date, all notifications and reports required under this CIA shall be submitted to the following entities: OIG: Administrative and Civil Remedies Branch Office of Counsel to the Inspector General Office of Inspector General U.S. Department of Health and Human Services Xxxxx Building, Room 5527 000 Xxxxxxxxxxxx Xxxxxx, X.X. Washington, DC 20201 Telephone: 000.000.0000 Facsimile: 202.205.0604 Indivior: Xxxxx Xxxxxx Chief Integrity & Compliance Officer Indivior Inc. 00000 Xxxxxxxxxx Xxxxxxxx Xxxxx Xxxxxxxxxxxx, XX 00000 Telephone: 000-000-0000 Email: Xxxxx.xxxxxx@xxxxxxxx.xxx Unless otherwise specified, all notifications and reports required by this CIA may be made by electronic mail, overnight mail, hand delivery, or other means, provided that there is proof that such notification was received. Upon request by OIG, Indivior may be required to provide OIG with an additional copy of each notification or report required by this CIA in OIG’s requested format (electronic or paper).

NOTIFICATIONS AND SUBMISSION OF REPORTS. Unless otherwise stated in writing after the Effective Date, all notifications and reports required under this CIA shall be submitted to the following entities: OIG: Administrative and Civil Remedies Branch Office of Counsel to the Inspector General Office of Inspector General U.S. Department of Health and Human Services Xxxxx Building, Room 5527 000 Xxxxxxxxxxxx Xxxxxx, X.X. Washington, DC 20201 Telephone: 000.000.0000 Facsimile: 202.205.0604 IndiviorProgenity: Xxxxx Xxxxxx Hutan Xxxxxxx Chief Integrity & Compliance Officer Indivior Progenity, Inc. 00000 Xxxxxxxxxx Xxxxxxxx 0000 Xx Xxxxx XxxxxxxxxxxxXxxxxxx Xxxxx, Xxxxx 000 Xxx Xxxxx, XX 00000 Telephone: 000-000-0000 000.000.0000 Email: Xxxxx.xxxxxx@xxxxxxxx.xxx Xxxxx.Xxxxxxx@Xxxxxxxxx.xxx Unless otherwise specified, all notifications and reports required by this CIA may be made by electronic mail, overnight mail, hand delivery, or other means, provided that there is proof that such notification was received. For purposes of this requirement, internal facsimile confirmation sheets do not constitute proof of receipt. Upon request by OIG, Indivior Progenity may be required to provide OIG with an additional copy of each notification or report required by this CIA CIA, in OIG’s requested format (electronic or paper).

NOTIFICATIONS AND SUBMISSION OF REPORTS. ‌ Unless otherwise stated in writing after the Effective Date, all notifications and reports required under this CIA shall be submitted to the following entities: OIG: OIG:‌ Administrative and Civil Remedies Branch Office of Counsel to the Inspector General Office of Inspector General General‌ U.S. Department of Health and Human Services Xxxxx Building, Room 5527 000 Xxxxxxxxxxxx Xxxxxx, X.X. WashingtonXxxxxxxxxx, DC 20201 XX 00000 Telephone: 000.000.0000‌ Facsimile: 202.205.0604 ResMed:‌ Xxx Xxxxx, Chief Compliance Officer ResMed Corp. 0000 Xxxxxxxx Xxxxxx Xxxx. Xxx Xxxxx, XX 00000 Telephone: 000.000.0000 Facsimile: 202.205.0604 Indivior: Xxxxx Xxxxxx Chief Integrity & Compliance Officer Indivior Inc. 00000 Xxxxxxxxxx Xxxxxxxx Xxxxx Xxxxxxxxxxxx, XX 00000 Telephone: 000-000-0000 858.836.5518 Email: Xxxxx.xxxxxx@xxxxxxxx.xxx xxx.xxxxx@xxxxxx.xxx Unless otherwise specified, all notifications and reports required by this CIA may shall be made by electronic mail, overnight mail, hand delivery, or other means, provided that there is proof that such notification was received. For purposes of this requirement, internal facsimile confirmation sheets do not constitute proof of receipt. Upon request by OIG, Indivior ResMed may be required to provide OIG with an additional copy of each notification or report required by this CIA CIA, in OIG’s requested format (electronic or paper).

NOTIFICATIONS AND SUBMISSION OF REPORTS. ‌ Unless otherwise stated in writing after the Effective Date, all notifications and reports required under this CIA shall be submitted to the following entities: OIG: OIG:‌ Administrative and Civil Remedies Branch Office of Counsel to the Inspector General Office of Inspector General General‌ U.S. Department of Health and Human Services Xxxxx Building, Room 5527 000 Xxxxxxxxxxxx Xxxxxx, X.X. WashingtonXxxxxxxxxx, DC 20201 XX 00000 Telephone: 000.000.0000 Facsimile: 202.205.0604 IndiviorInsys:‌ Insys Therapeutics, Inc. Attention: General Counsel 0000 Xxxxx Xxxxxx Chief Integrity & Compliance Officer Indivior Inc. 00000 Xxxxxxxxxx Xxxxxxxx Xxxx. Xxxxx Xxxxxxxxxxxx000 Xxxxxxxx, XX 00000 Telephone: 000-000-0000 Email000.000.0000 Facsimile: Xxxxx.xxxxxx@xxxxxxxx.xxx 602.910.2627 Unless otherwise specified, all notifications and reports required by this CIA may be made by electronic mail, overnight mail, hand delivery, or other means, provided that there is proof that such notification was received. Upon request by OIG, Indivior Insys may be required to provide OIG with an additional copy of each notification or report required by this CIA in OIG’s requested format (electronic or paper).

NOTIFICATIONS AND SUBMISSION OF REPORTS. Unless otherwise stated in writing after the Effective Date, all notifications and reports required under this CIA shall be submitted to the following entities: OIG: Administrative and Civil Remedies Branch Office of Counsel to the Inspector General Office of Inspector General General‌‌ U.S. Department of Health and Human Services Xxxxx Building, Room 5527 5527‌ 000 Xxxxxxxxxxxx Xxxxxx, X.X. WashingtonXxxxxxxxxx, DC 20201 XX 00000‌ Telephone: 000.000.0000 Facsimile: 202.205.0604 Indivior: Xxxxx Xxxxxx Chief Integrity & Compliance Officer Indivior Inc. 00000 Xxxxxxxxxx Xxxxxxxx Xxxxx Xxxxxxxxxxxx, XX 00000 Telephone: 000-000-0000 Email: Xxxxx.xxxxxx@xxxxxxxx.xxx Unless otherwise specified, all notifications and reports required by this CIA may be made by electronic mail, overnight mail, hand delivery, or other means, provided that there is proof that such notification was received. Upon request by OIG, Indivior may be required to provide OIG with an additional copy of each notification or report required by this CIA in OIG’s requested format (electronic or paper).

NOTIFICATIONS AND SUBMISSION OF REPORTS. Unless otherwise stated in writing after the Effective Date, all notifications and reports required under this CIA shall be submitted to the following entities: OIG: Administrative and Civil Remedies Branch Office of Counsel to the Inspector General Office of Inspector General U.S. Department of Health and Human Services Xxxxx Building, Room 5527 000 Xxxxxxxxxxxx Xxxxxx, X.X. WashingtonXxxxxxxxxx, DC 20201 XX 00000 Telephone: 000.000.0000 Facsimile: 202.205.0604 Indivior: Xxxxx Xxxxxx Chief Integrity & Compliance Officer Indivior Inc. 00000 Xxxxxxxxxx Xxxxxxxx Xxxxx Xxxxxxxxxxxx, XX 00000 Telephone: 000-000-0000 Email: Xxxxx.xxxxxx@xxxxxxxx.xxx Unless otherwise specified, all notifications and reports required by this CIA may be made by electronic mail, overnight mail, hand delivery, or other means, provided that there is proof that such notification was received. Upon request by OIG, Indivior may be required to provide OIG with an additional copy of each notification or report required by this CIA in OIG’s requested format (electronic or paper).

NOTIFICATIONS AND SUBMISSION OF REPORTS. Unless otherwise stated in writing after the Effective Date, all notifications and reports required under this CIA shall be submitted to the following entities: OIG: Administrative and Civil Remedies Branch Office of Counsel to the Inspector General Office of Inspector General U.S. Department of Health and Human Services Xxxxx Building, Room 5527 000 Xxxxxxxxxxxx Xxxxxx, X.X. WashingtonXxxxxxxxxx, DC 20201 XX 00000 Telephone: 000.000.0000 Facsimile: 202.205.0604 IndiviorUnited Therapeutics: Xxxxx Xxxxxx Xxxxxxx XxXxxxx Senior Vice President Chief Integrity & Compliance Officer Indivior Inc. 00000 Xxxxxxxxxx Xxxxxxxx Xxxxx Xxxxxxxxxxxx0000 Xxxxxxxxxxx Xxx, X.X. Xxxxxxxxxx, XX 00000 Telephone: 000-000-0000 Email000.000.0000 Facsimile: Xxxxx.xxxxxx@xxxxxxxx.xxx 202.518.8477 Unless otherwise specified, all notifications and reports required by this CIA may be made by electronic mail, overnight mail, hand delivery, or other means, provided that there is proof that such notification was received. Upon request by OIG, Indivior United Therapeutics may be required to provide OIG with an additional electronic copy of each notification or report required by this CIA in OIG’s requested format (electronic or paper)addition to a paper copy.

NOTIFICATIONS AND SUBMISSION OF REPORTS. Unless otherwise stated in writing after the Effective Date, all notifications and reports required under this CIA shall be submitted to the following entities: OIG: Administrative and Civil Remedies Branch Office of Counsel to the Inspector General Office of Inspector General General‌ U.S. Department of Health and Human Services Xxxxx Building, Room 5527 000 Xxxxxxxxxxxx Xxxxxx, X.X. Washington, DC 20201 Telephone: 000.000.0000 Facsimile: 202.205.0604 IndiviorSaber: Xxxxx Xxxxxx Xxxxxxxx Xx Chief Integrity & Compliance Officer Indivior Inc. 00000 Xxxxxxxxxx Xxxxxxxx Xxxxx XxxxxxxxxxxxXxxx Xxxxxxx Xxxxxxx, XX Xxxx 00000 Telephone: 000-000-0000 000.000.0000 Facsimile:216.342.6804 Email: Xxxxx.xxxxxx@xxxxxxxx.xxx xxxxxxxx.xx@xxxxxxxxxxx.xxx Unless otherwise specified, all notifications and reports required by this CIA may be made by electronic mail, overnight mail, hand delivery, or other means, provided that there is proof that such notification was received. Upon request by OIG, Indivior Saber may be required to provide OIG with an additional copy of each notification or report required by this CIA in OIG’s requested format (electronic or paper).

NOTIFICATIONS AND SUBMISSION OF REPORTS. Unless otherwise stated in writing after the Effective Date, all notifications and reports required under this CIA shall be submitted to the following entities: OIG: Administrative and Civil Remedies Branch Office of Counsel to the Inspector General Office of Inspector General U.S. Department of Health and Human Services Xxxxx Building, Room 5527 000 Xxxxxxxxxxxx Xxxxxx, X.X. Washington, DC 20201 Telephone: 000.000.0000 Facsimile: 202.205.0604 IndiviorMallinckrodt: Xxxxx Xxxxxx Xxxxxxx Senior Vice President and Chief Integrity & Compliance Officer Indivior Inc. 00000 Xxxxxxxxxx Xxxxxxxx Xxxxx XxxxxxxxxxxxXxxxxxxxxxxx Pharmaceuticals 000 XxXxxxxxx Xxxx. Hazelwood, XX 00000 MO 63042 Telephone: 000-000-0000 000.000.0000 Email: Xxxxx.xxxxxx@xxxxxxxx.xxx Xxxxxx.Xxxxxxx@xxx.xxx Unless otherwise specified, all notifications and reports required by this CIA may be made by electronic mail, overnight mail, hand delivery, or other means, provided that there is proof that such notification was received. Upon request by OIG, Indivior Mallinckrodt may be required to provide OIG with an additional copy of each notification or report required by this CIA in the OIG’s requested format (electronic or paper).